Cellular response to bioactive ceramics

Bioceramics and their Clinical Applications

Volumn , Issue , 2008, Pages 133-164

  Knabe, Christine ^a,b   Ducheyne, Paul ^c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVE CERAMIC; CELLULAR RESPONSE;

EID: 84902052472     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1533/9781845694227.1.133     Document Type: Chapter

References (131)

1. Ducheyne P., Hench L.L., Kagan A., Martens M., Mulier J.C., Burssens A. The effect of hydroxyapatite impregnation on bonding of porous coated implants. J Biomed Mat Res 1980, 14:225-237.
2. De Groot K., Wolke J.G., Jansen J.A. Calcium phosphate coatings for medical implants. Proc Inst Mech Eng 1998, 212:137-147. Review.
3. Geesink R.G. Osteoconductive coatings for total joint arthroplasty. Clin Orthop 2002, 395:53-65. Review.
4. Ducheyne P. Hip Surgery: New Materials and Developments. Bioactive calcium phosphate ceramics and glasses 1998, 75-82. Martin Dunitz, London. L. Sedel, M. Cabanela (Eds.).
5. Denissen H.W., Klein C.P., Visch L.L., Van Den Hooff A. Behavior of calcium phosphate coatings with different chemistries in bone. Int J Prosthodont 1996, 9:142-148.
6. Ducheyne P., Beight J., Cuckler J., Evans B., Radin S. Effect of calcium phosphate coating characteristics on early post-operative bone tissue ingrowth. Biomaterials 1990, 11:531-540.
7. Knabe C., Berger G., Gildenhaar R., Klar F., Zreiqat H. The modulation of osteogenesis in vitro by calcium titanium phosphate coatings. Biomaterials 2004, 25:4911-4919.
8. Buser D., Dula K., Hess D., Hirt H.P., Belser U.C. Localized ridge augmentation with autografts and barrier membranes. Periodontology 2000 1999, 19:151-163. Review.
9. von Arx T., Cochran D.L., Hermann J.S., Schenk R.K., Buser D. Lateral ridge augmentation using different bone fillers and barrier membrane application. A histologic and histomorphometric pilot study in the canine mandible. Clin Oral Implants Res 2001, 12:260-269.
10. Praemer A., Furner S., Rice D.P. Musculoskeletal Conditions in the United States 1999, American Academy of Orthopaedic Surgeons, Park Ridge.
11. Belser U.C., Mericske-Stern R., Bernard J.P., Taylor T.D. Prosthetic management of the partially dentate patient with fixed implant restorations. Clin Oral Implants Res 2000, 11(Suppl 1):126-145. Review.
12. Ganz S.D., Valen M. Predictable synthetic bone grafting procedures for implant reconstruction: part two. J Oral Implantol 2002, 28:178-183.
13. Winkler S. Implant site development and alveolar bone resorption patterns. J Oral Implantol 2002, 28:226-229.
14. Kalk W.W., Raghoebar G.M., Jansma J., Boering G. Morbidity from iliac crest bone harvesting. J Oral Maxillofac Surg 1996, 54:1424-1429.
15. Kaptein M.L., Hoogstraten J., de Putter C., de Lange G.L., Blijdorp P.A. Dental implants in the atrophic maxilla: measurements of patients' satisfaction and treatment experience. Clin Oral Implants Res 1998, 9:321-326.
16. Wheeler S.L. Sinus augmentation for dental implants: the use of alloplastic materials. J Oral Maxillofac Surg 1997, 55:1287-1293. Review.
17. Ouhayoun J.P. Risques de transmission à l'homme de pathologies virale par de substituts oseux d'origine humaine ou animale. Rapport sur l'état des recherches concernant les risques associés à l'utilisation à des fins thérapeutiques de produits d'origine humaine ou de produits et procédés de substitution 1995, 224-230. Paris. INSERM.
18. Metsger D.S., Driskell T.D., Paulsrud J.R. Tricalcium phosphate ceramic - a resorbable bone implant: review and current status. J Am Dent Assoc 1982, 105:1035-1038. Review.
19. Hollinger J.O., Brekke J., Gruskin E., Lee D. Role of bone substitutes. Clin Orthop 1996, 324:55-65. Review.
20. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.C. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996, 17:175-185.
21. Hench L.L. Bioceramics. J Am Ceram Soc 1998, 81:1705-1728. Review.
22. Zerbo I.R., Bronckers A.L., de Lange G.L., van Beek G.J., Burger E.H. Histology of human alveolar bone regeneration with a porous tricalcium phosphate. A report of two cases. Clin Oral Implants Res 2001, 12:379-384.
23. Wiltfang J., Merten H.A., Schlegel K.A., Schultze-Mosgau S., Kloss F.R., Rupprecht S., Kessler P. Degradation characteristics of alpha and beta tri-calcium-phosphate (TCP) in minipigs. J Biomed Mater Res 2002, 63:115-121.
24. Zerbo I.R., Zijderveld S.A., de Boer A., Bronckers A.L., de Lange G., ten Bruggenkate C.M., Burger E.H. Histomorphometry of human sinus floor augmentation using a porous β-tricalcium phosphate: a prospective study. Clin Oral Implants Res 2004, 15:724-732.
25. Zerbo I.R., Bronckers A.L., de Lange G., Burger E.H. Localisation of osteogenic and osteoclastic cells in porous β-tricalcium phosphate particles used for human maxillary sinus floor elevation. Biomaterials 2005, 26:1445-1451.
26. Szabo G., Huys L., Coulthard P., Maiorana C., Garagiola U., Barabas J., Nemeth Z., Hrabak K., Suba Z. A prospective multicenter randomized clinical trial of autogenous bone versus β-tricalcium phosphate graft alone for bilateral sinus elevation: histologic histomorphometric evaluation. Int J Oral Maxillofac Implants 2005, 20:371-381.
27. Eggli P.S., Muller W., Schenk R.K. Porous hydroxyapatite and tricalcium phosphate cylinders with two different pore size ranges implanted in the cancellous bone of rabbits. Clin Orthop Rel Res 1988, 232:127-138.
28. Ducheyne P., de Groot K. In vivo surface activity of a hydroxyapatite alveolar bone substitute - a note. J Biomed Mat Res 1991, 15:441-445.
29. Tadjoedin E.S., de Lange G.L., Holzmann P.J., Kulper L., Burger E.H. Histological observations on biopsies harvested following sinus floor elevation using a bioactive glass material of narrow size range. Clin Oral Implants Res 2000, 11:334-344.
30. Tadjoedin E.S., de Lange G.L., Lyaruu D.M., Kuiper L., Burger E.H. High concentrations of bioactive glass material (BioGran) vs. autogenous bone for sinus floor elevation. Clin Oral Implants Res 2002, 13:428-436.
31. Peters F., Reif D. Functional materials for bone regeneration from β-tricalcium phosphate. Materialwissenschaft und Werkstofftechnik 2004, 35:203-207.
32. Knabe C., Ch Koch, Rack A., Stiller M. Histological and immunohistochemical study of biopsies sampled after sinus floor augmentation using tricalcium phosphate particles with varying porosity 2006, 371. Society for Biomaterials USA, Pennsylvania, USA.
33. Knabe C., Koch Ch, Rack A., Stiller M. Effect of β-tricalcium phosphate particles with varying porosity on osteogenesis after sinus floor augmentation in humans. Biomaterials 2008, in press.
34. Timmenga N.M., Raghoebar G.M., van Weissenbruch R., Vissink A. Maxillary sinus floor elevation surgery. A clinical, radiographic and endoscopic evaluation. Clin Oral Implants Res 2003, 14:322-328.
35. Artzi Z., Kozlovsky A., Nemcovsky C.E., Weinreb M. The amount of newly formed bone in sinus grafting procedures depends on tissue depth as well as the type and residual amount of the grafted material,. J Clin Periodontol 2005, 32:193-199.
36. Zijderveld S.A., Zerbo I.R., Van Den Bergh J.P., Schulten E.A., ten Bruggenkate C.M. Maxillary sinus floor augmentation using a beta-tricalcium phosphate (Cerasorb) alone compared to autogenous bone grafts. Int J Oral Maxillofac Implants 2005, 20:432-440.
37. Suba Z., Takacs D., Matusovits D., Barabas J., Fazekas A., Szabo G. Maxillary sinus floor grafting with β-tricalcium phosphate in humans: density and microarchitecture of the newly formed bone. Clin Oral Implants Res 2006, 17:102-108.
38. Berger G., Gildenhaar R., Ploska U. Rapid resorbable, glassy crystalline materials on the basis of calcium alkali orthophosphates. Biomaterials 1995, 16:1241-1248.
39. 2 1995, 453-456. Butterworth-Heinemann, Oxford. J. Wilson, L.L. Hench, D.C. Greenspan (Eds.).
40. 2. Cryst Res Technol 1994, 29:671-675.
41. Knabe C., Gildenhaar R., Berger G., Ostapowicz W., Fitzner R., Radlanski R.J., Gross U. In vitro investigation of novel calcium phosphates using osteogenic cultures. J Mater Sci Mater Med 1998, 9:337-345.
42. Knabe C., Berger G., Gildenhaar R., Meyer J., Howlett C.R., Markovic B., Zreiqat H. The effect of rapidly resorbable calcium phosphates and a calcium phos phate bone cement on the expression of bone-related genes and proteins in vitro. J Biomed Mater Res 2004, 69A:145-154.
43. Knabe C., Houshmand A., Berger G., Ducheyne P., Gildenhaar R., Stiller M. Effect of rapidly resorbable bone substitute materials on the temporal expression of the osteoblastic phenotype in vitro. J Biomed Mater Res A 2007, Epub ahead of print.
44. Knabe C., Berger G., Gildenhaar R., Ch Koch, Jonscher S., Rack A., Seligmann H., Stiller M. Effect of rapidly resorbable calcium-alkali-orthophosphate bone substitute materials on osteogenesis and osteoblastic phenotype expression in vivo 2007, 262. Illinois, USA. sssss (Ed.).
45. Schmitz J.P., Hollinger J.O., Milam S.B. Reconstruction of bone using calcium phosphate bone cements: a critical review. J Oral Maxillofac Surg 1999, 57:1122-1126.
46. Khairoun I., Boltong M.G., Driessens F.C.M., Planell J.A. Effect of calcium carbonate on the compliance of an apatitic bone cement. Biomaterials 1997, 18:1535-1539.
47. Ooms E.M., Wolke J.G., van der Waerden J.P., Jansen J.A. Trabecular bone response to injectable calcium phosphate (Ca-P) cement. J Biomed Mater Res 2002, 61:9-18.
48. Cuisinier F.J.G., Wieber A., Tenenbaum H., van Landuyt P., Lemaitre J. Injectable calcium phosphate hydraulic cement (CPHC) used as periodontal tissues regeneration. A study in a dog model. J Appl Biomater Biomech 2003, 1:186-193.
49. Wolff K.D., Swaid S., Nolte D., Bockmann R.A., Holzle F., Muller-Mai C. Degradable injectable bone cement in maxillofacial surgery: indications and clinical experience in 27 patients. J Craniomaxillofac Surg 2004, 32:71-79.
50. Gildenhaar R., Berger G., Knabe C., Lehmann E. Development of alkali containing calcium phosphate cements. Key Eng Mater 2008, 361-3:331-334.
51. Ducheyne P., Qiu Q. Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function. Biomaterials 1999, 20:2287-2303. Review.
52. Hench L.L. Bioactive glasses, ceramics, and composites. Bone-Implant Interface 1994, 9:181-190. Review.
53. Ohgushi H., Okumura M., Tamai S., Shors E.C., Caplan A.I. Marrow cell induced osteogenesis in porous hydroxyapatite and tricalcium phosphate: a comparative histomorphometric study of ectopic bone formation. J Biomed Mater Res 1990, 24:1563-1570.
54. Ducheyne P., Bianco P., Radin S., Schepers E. Bone-bioactive Biomaterials. Bioactive materials: mechanisms and bioengineering considerations 1993, 1-12. Reed Healthcare Communications, Leiderdorp, Netherlands. P. Ducheyne, T. Kokubo, C.A. van Blitterswijk (Eds.).
55. Radin S.R., Ducheyne P. The effect of calcium phosphate ceramic composition and structure on in vitro behavior. II. Precipitation. J Biomed Mat Res 1993, 27:35-45.
56. Radin S., Ducheyne P. Effect of serum proteins on solution-induced surface transformations of bioactive ceramics. J Biomed Mater Res 1996, 30:273-279.
57. Radin S., Ducheyne P., Rothman B., Conti A. The effect of in vitro modeling conditions on the surface reactions on bioactive glass. J Biomed Mat Res 1997, 37:363-375.
58. Radin S., Ducheyne P., Berthold P., Decker S. Effect of serum proteins and osteoblasts on the surface transformation of a calcium phosphate coating: a physicochemical and ultrastructural study. J Biomed Mat Res 1997, 39:234-243.
59. Kokubo T., Kushitani H., Ohtsuki C., Sakka S., Yamamuro T. Chemical-reaction of bioactive glass and glass-ceramics with a simulated body-fluid. J Mater Sci Mater Med Sci 1992, 3:79-83.
60. Kokubo T. Bone-bioactive Biomaterials. Bioactivity of glasses and glass ceramics 1993, 31-46. Reed Healthcare Communications, Leiderdorp, Netherlands. P. Ducheyne, T. Kokubo, C.A. van Blitterswijk (Eds.).
61. El-Ghannam A., Ducheyne P., Shapiro I.M. Effect of serum protein adsorption on osteoblast adhesion to bioactive glass and hydroxyapatite. J Orthop Res 1999, 17:340-345.
62. Kaufmann E.A., Ducheyne P., Radin S., Bonnell D.A., Composto R. Initial events at the bioactive glass surface in contact with protein containing solutions,. J Biomed Mat Res 2000, 52:825-830.
63. Hench L., Splinter R., Greenlee T., Allen W. Bonding mechanisms at the interface of ceramic prosthetic materials. J Biomed Eng 1971, 2:117-141.
64. LeGeros R.Z., Daculsi G., Orly I., Gregoire M., Heughebaert M., Gineste M., Kijkowska R. Bone-bonding Biomaterials. Formation of carbonate apatite on calcium phosphate materials: dissolution/precipitation processes 1993, 201-212. Reed Healthcare Communications, Leiderdorp, Netherlands. P. Ducheyne, T. Kokubo, C.A. van Blitterswijk (Eds.).
65. Ducheyne P., Radin S., King L. The effect of calcium-phosphate ceramic composition and structure on in vitro behavior; I. Dissolution. J Biomed Mat Res 1993, 27:25-34.
66. Neo M., Nakaruma T., Yamamuro T., Ohtsuki C., Kokubo T. Bone-bonding Biomaterials. Transmission microscopic study of apatite formation on bioactive ceramics in vivo 1993, 111-120. Reed Healthcare Communications, Leiderdorp, Netherlands. P. Ducheyne, T. Kokubo, C.A. van Blitterswijk (Eds.).
67. Ducheyne P., Kim C.S., Pollack S.R. The effect of phase differences on the time-dependent variation of the zeta potential of hydroxyapatite. J Biomed Mat Res 1992, 26:147-168.
68. El-Ghannam A.E., Ducheyne P., Shapiro I. Porous bioactive glass and hydroxyapatite stimulate bone cell function in vitro along different time lines. J Biomed Mater Res 1997, 36:167-180.
69. Yao J., Radin S., Leboy P.S., Ducheyne P. Solution mediated effect of bioactive glass in poly (lactic-co-glycolic acid)-bioactive glass composites on osteogenesis of marrow stromal cells. J Biomed Mater Res A 2005, 75:794-801.
70. De Bruijn J.D., Bovell Y.P., van Blitterswijk C.A. Structural arrangements at the interface between plasma sprayed calcium phosphates and bone. Biomaterials 1994, 15:543-550.
71. Daculsi G., LeGeros R.Z., Nery E., Lynch K., Kerebel B. Transformation of biphasic calcium phosphate ceramics in vivo: ultrastructural and physicochemical characterization. J Biomed Mat Res 1989, 23:883-894.
72. De Bruijn J.D., Davies J.E., Klein C.P.A.T., de Groot K., van Blitterswijk C.A. Bone-bonding Biomaterials. Biological responses to calcium phosphate ceramics 1993, 57-72. Reed Healthcare Communications, Leiderdorp, Netherlands. P. Ducheyne, T. Kokubo, C.A. van Blitterswijk (Eds.).
73. El-Ghannam A., Ducheyne P., Shapiro I.M. Bioactive material template for in vitro synthesis of bone. J Biomed Mat Res 1995, 29:359-370.
74. Schepers E., Declercq M., Ducheyne P., Kempeneers R. Bioactive glass particulate material as a filler for bone lesions. J Oral Rehab 1991, 18:439-452.
75. Matsuda T., Davies J.E. The in vitro response of osteoblasts to bioactive glass. Biomaterials 1987, 8:275-284.
76. Radin S.R., Ducheyne P. The effect of calcium phosphate ceramic composition and structure on in vitro behavior. II. Precipitation. J Biomed Mat Res 1993, 27:35-45.
77. Davies J.E. Mechanisms of endosseous integration. Int J Prosthodont 1998, 11:391-401. Review.
78. Hench L.L. Bioceramics: from concept to clinic. J Am Cer Soc 1991, 74(7):1487-1510.
79. Keselowsky B.G., Collard D.M., Garcia A.J. Surface chemistry modulates fibronectin conformation and directs integrin binding and specifi city to control cell adhesion. J Biomed Mater Res A 2003, 66:247-259.
80. Ducheyne P., El-Ghannam A., Shapiro I. Effect of bioactive glass templates on osteoblast proliferation and in vitro synthesis of bone like tissue. J Cell Biochem 1994, 56:162-167.
81. Xynos I.D., Edgar A.J., Buttery L.D., Hench L.L., Polak J.M. Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor II mRNA expression and protein synthesis. Biochem Biophys Res Commun 2000, 276:461-465.
82. Xynos I.D., Edgar A.J., Buttery L.D., Hench L.L., Polak J.M. Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution. J Biomed Mater Res 2001, 55:151-157.
83. Xynos I.D., Hukkanen M.V., Batten J.J., Buttery L.D., Hench L.L., Polak J.M. Bioglass 45S5 stimulates osteoblast turnover and enhances bone formation in vitro: implications and applications for bone tissue engineering. Calcif Tissue Int 2000, 67:321-329.
84. El-Ghannam A., Ducheyne P., Shapiro I.M. Formation of surface reaction products on bioactive glass and their effects on the expression of the osteoblastic phenotype and the deposition of mineralized extracellular matrix. Biomaterials 1997, 18:295-303.
85. Radin S., Reilly G., Bhargave G., Leboy P.S., Ducheyne P. Osteogenic effects of bioactive glass on bone marrow stromal cells. J Biomed Mat Res 2005, 73A:21-29.
86. Sodek J., Cheifitz S. Bone Engineering. Molecular regulation of osteogenesis 2000, 31-43. em squared Inc, Toronto, Canada. J.E. Davies (Ed.).
87. Aubin J.E. Advances in the osteoblast lineage. Biochem Cell Biol 1998, 76:899-910. Review.
88. Aubin J.E. Bone Engineering. Osteogenic cell differentiation 2000, 19-30. em squared Inc, Toronto, Canada. J.E. Davies (Ed.).
89. Fisher L.W., Termine J.D. Noncollagenous proteins influencing the local mechanisms of calcification. Clin Orthop 1985, 200:362-385.
90. Termine J.D., Kleinman H.K., Whitson S.W., Conn K.M., McGarvey M.L., Martin G.R. Osteonectin, a bone-specific protein linking mineral to collagen. Cell 1981, 26:99-105.
91. Oldberg A., Franzen A., Heinegard D. The primary structure of a cell-binding bone sialoprotein. J Biol Chem 1988, 263:19430-19432.
92. Schwartz Z., Boyan B.D. Underlying mechanisms at the bone-biomaterial interface. J Cell Biochem 1994, 56:340-347. Review.
93. Howlett C.R., Chen N., Zhang X., Akin F.A., Haynes D., Hanley L., Revell P., Evans P., Zhou H., Zreiqat H. Bone Engineering. The effect of biomaterial chemistries on the osteoblastic molecular phenotype and osteogenesis: in vitro and in vivo studies 2000, 240-255. em squared Inc, Toronto, Canada. J.E. Davies (Ed.).
94. Salih V., Franks K., James M., Hastings G.W., Knowles J.C. Development of soluble glasses for biomedical use. Part 2: The biological response of human osteoblast cell lines to phosphate-based soluble glasses. J Mater Sci Mater Med Sci 2000, 11:615-620.
95. Knabe C., Stiller M., Berger G., Reif D., Gildenhaar R., Howlett C.R., Zreiqat H. The effect of bioactive glass ceramics on the expression of bone-related genes and proteins in vitro. Clin Oral Implants Res 2005, 16:119-127.
96. Knabe C., Howlett C.R., Klar F., Zreiqat H. The effect of different titanium and hydroxyapatite-coated dental implant surfaces on phenotypic expression of human bone-derived cells. J Biomed Mater Res 2004, 71A:98-107.
97. Knabe C., Berger G., Gildenhaar R., Howlett C.R., Markovic B., Zreiqat H. The functional expression of human bone-derived cells grown on rapidly resorbable calcium phosphate ceramics. Biomaterials 2004, 25:335-344.
98. Wang C., Duan Y., Markovic B., James B., Howlett C.R., Zhang X., Zreiqat H. Phenotypic expression of bone-related genes in osteoblasts grown on calcium phosphate ceramics with different phase compositions. Biomaterials 2004, 25:2507-2514.
99. Krause A., Cowles E.A., Gronowicz G. Integrin-mediated signaling in osteoblasts on titanium implant materials. J Biomed Mater Res 2000, 52:738-747.
100. Gronowicz G., McCarthy M.B. Response of human osteoblasts to implant materials: integrin-mediated adhesion. J Orthop Res 1996, 14:878-887.
101. Rezania A., Healy K.E. Integrin subunits responsible for adhesion of human osteoblast-like cells to biomimetic peptide surfaces. J Orthop Res 1999, 17:615-623.
102. Cowles E.A., Brailey L.L., Gronowicz G.A. Integrin-mediated signaling regulates AP-1 transcription factors and proliferation in osteoblasts. J Biomed Mater Res 2000, 52:725-737.
103. Hynes R.O. Integrins: a family of cell surface receptors. Cell 1987, 48:549-554.
104. Hynes R.O. Integrins: versatility, modulation, and signaling in cell adhesion. Cell 1992, 69:11-25. Review.
105. Gronthos S., Stewart K., Graves S.E., Hay S., Simmons P.J. Integrin expression and function of human osteoblast-like cells. J Bone Miner Res 1997, 12:1189-1197.
106. Hughes D.E., Salter D.M., Dedhar S., Simpson R. Integrin expression in human bone. J Bone Miner Res 1993, 8:527-533.
107. Saito T., Albelda S.M., Brighton C.T. Identification of integrin receptors on cultured human bone cells. J Orthop Res 1994, 12:384-394.
108. Garcia A.J., Ducheyne P., Boettiger D. Effect of surface reaction stage on fibronectin-mediated adhesion of osteoblast-like cells to bioactive glass. J Biomed Mater Res 1998, 40:48-56.
109. Danen E.H., Aota S., van Kraats A.A., Yamada K.M., Ruiter D.J., van Muijen G.N. Requirement for the synergy site for cell adhesion to fibronectin depends on the activation state of integrin alpha 5 beta. J Biol Chem 1995, 270(37):21612-21618.
110. Keselowsky B.G., Collard D.M., Garcia A.J. Integrin binding specificity regulates biomaterial surface chemistry effects on cell differentiation. Proc Natl Acad Sci USA 2005, 102(17):5953-5957.
111. Juliano R.L., Haskill S. Signal transduction from the extracellular matrix. J Cell Biol 1993, 120:577-585.
112. Rosales C., O'Brien V., Kronberg L., Julinao R.L. Signal transduction by cell adhesion receptors. Biochem Biophys Acta 1995, 1242:77-98.
113. Bates R.C., Lincz L.F., Burns G.F. Involvement of integrins in cell survival. Cancer Metastasis Rev 1995, 14:191-203. Review.
114. Yamada K.M., Miyamoto S. Integrin transmembrane signaling and cytoskeletal control. Curr Opin Cell Biol 1995, 7:681-689. Review.
115. Richardson A., Parsons J.T. Signal transduction through integrins: a central role for focal adhesion kinase?. Bioessays 1995, 17:229-236.
116. Dedhar S. Integrin-mediated signal transduction in oncogenesis: an overview. Cancer Metastasis Rev 1995, 14:165-172.
117. Harmer S.L., DeFranco A.L. Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes. Mol Cell Biol 1997, 17:4087-4095.
118. Noth U., Tuli R., Seghatoleslami R., Howard M., Shah A., Hall D.J. Activation of p38 and Smads mediates BMP-2 effects on human trabecular bone-derived osteoblasts. Exp Cell Res 2003, 291(1):201-211.
119. Nohe A., Keating E., Knaus P., Petersen N.O. Signal transduction of bone morphogenetic protein receptors. Cell Signal 2004, 16:291-299.
120. Ivaska J., Reunanen H., Westermarck J., Koivisto L., Kahari V.M., Heino J. Integrin alpha2beta1 mediates isoform-specific activation of p38 and upregulation of collagen gene transcription by a mechanism involving the alpha2 cytoplasmic tail. J Cell Biol 1999, 147:401-416.
121. Adams C.S., Shapiro I.M. Mechanisms by which extracellular matrix components induce osteoblast apoptosis. Connect Tissue Res 2003, 44(Suppl 1):230-239. Review.
122. Grigoriou V., Shapiro I.M., Cavalcanti-Adam E.A., Composto R.J., Ducheyne P., Adams C.S. Osteoblast apoptosis and survival is regulated by integrinmediated surface attachment. J Biol Chem 2005, 280:1733-1739.
123. Risbud M.V., Fertala J., Vresilovic E.J., Albert T.J., Shapiro I.M. Nucleus pulposus cells upregulate PI3K/Akt and MEK/ERK signaling pathways under hypoxic conditions and resist apoptosis induced by serum withdrawal. Spine 2005, 30:882-889.
124. Razzouk S., Shapiro I.M. Detection of apoptotic gene expression in human osteoblast-like cells by cDNA microarrays. J Bone Miner Metab 2003, 21(5):261-267.
125. Szymczyk K.H., Shapiro I.M., Adams C.S. Ionizing radiation sensitizes bone cells to apoptosis. Bone 2004, 34:148-156.
126. Knabe C., Kraska B., Koch Ch, Gross U., Zreiqat H., Stiller M. A method for immunohistochemical detection of osteogenic markers in undecalcified bone sections. Biotech Histochem 2006, 81:313-319.
127. Gross U.M., Strunz V. Surface staining of sawed sections of undecalcified bone containing alloplastic implants. Stain Technol 1977, 52:217-219.
128. Donath K., Breuner G. A method for the study of undecalcified bones and teeth with attached soft tissues: The Saege-Schliff (sawing and grinding) technique. J Oral Pathol 1982, 11:318-326.
129. Roeser K., Johansson C.B., Donath K., Albrektsson T. A new approach to demonstrate cellular activity in bone formation adjacent to implants. J Biomed Mater Res 2000, 51:280-291.
130. Johansson C.B., Röser K., Bolind P., Donath K., Albrektsson T. Bone-tissue formation and integration of titanium implants: an evaluation with newly developed enzyme and immunohistochemical techniques. Clin Implant Dent Relat Res 1999, 1:33-40.
131. 2 1997, 53-56. Butterworth-Heinemann, Oxford. L. Sedel, C. Rey (Eds.).